Xenon Pharmaceuticals Inc. Business Finance Contracts & Agreements
27 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (3)
- Purchase Agreements (1)
- Share Agreements (5)
- Stock Agreements (2)
- Underwriting Agreements (8)
- Warrant Agreements (6)
- Form of Pre-Funded Warrant (Filed With SEC on November 30, 2023)
- Underwriting Agreement, dated November 29, 2023, among Xenon Pharmaceuticals Inc., J.P. Morgan Securities LLC, Jefferies LLC, BofA Securities, Inc., Stifel, Nicolaus & Company,... (Filed With SEC on November 30, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 23, 2022)
- Underwriting Agreement, dated June 22, 2022, among Xenon Pharmaceuticals Inc., Jefferies LLC, J.P. Morgan Securities LLC, SVB Securities LLC and Stifel, Nicolaus & Company,... (Filed With SEC on June 23, 2022)
- Share Purchase Agreement, dated as of January 11, 2022, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Filed With SEC on January 12, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on October 6, 2021)
- Underwriting Agreement, dated October 5, 2021, among Xenon Pharmaceuticals Inc., Jefferies LLC, SVB Leerink LLC, and Stifel, Nicolaus & Company, Incorporated, as representatives... (Filed With SEC on October 6, 2021)
- Share Purchase Agreement, dated as of September 8, 2021, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Filed With SEC on September 8, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on March 10, 2021)
- Underwriting Agreement, dated March 9, 2021, among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several... (Filed With SEC on March 10, 2021)
- Amendment to Asset Purchase Agreement, dated August 4, 2020, by and between the Company and 1st Order Pharmaceuticals, Inc (Filed With SEC on August 6, 2020)
- Underwriting Agreement, dated January 22, 2020, among Xenon Pharmaceuticals Inc., Jefferies LLC, Stifel, Nicolaus & Company, Incorporated, and Guggenheim Securities, LLC as... (Filed With SEC on January 23, 2020)
- Underwriting Agreement, dated September 12, 2018, among Xenon Pharmaceuticals, Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several... (Filed With SEC on September 13, 2018)
- Amended and Restated Loan and Security Agreement, dated August 3, 2018, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank (Filed With SEC on August 7, 2018)
- Warrant to Purchase Shares, dated August 3, 2018, by and between Xenon Pharmaceuticals Inc. and Silicon Valley Bank (Filed With SEC on August 7, 2018)
- First Loan Modification to Loan and Security Agreement, dated June 12, 2018, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank (Filed With SEC on June 13, 2018)
- Exchange Agreement, dated March 23, 2018, by and among the Company and the shareholders listed in Schedule B thereto (Filed With SEC on March 28, 2018)
- Specimen Series 1 Preferred Share Certificate (Filed With SEC on March 28, 2018)
- Loan and Security Agreement, dated December 18, 2017, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank (Filed With SEC on December 18, 2017)
- Warrant to Purchase Shares, dated December 18, 2017, by and between Xenon Pharmaceuticals Inc. and Silicon Valley Bank (Filed With SEC on December 18, 2017)
- SHARE OPTION AGREEMENT (Filed With SEC on March 8, 2017)
- 4,000,000 Shares XenonPharmaceuticals Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 9, 2016)
- XENON PHARMACEUTICALS INC. AMENDED AND RESTATED STOCK OPTION PLAN (Filed With SEC on October 6, 2014)
- AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 6, 2014)
- [] Shares Xenon Pharmaceuticals Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 6, 2014)
- XENON PHARMACEUTICALS INC. COMMON SHARE PUT AGREEMENT March 19, 2014 XENON PHARMACEUTICALS INC. COMMON SHARE PUT AGREEMENT (Filed With SEC on September 10, 2014)
- XENON PHARMACEUTICALS INC. AMENDED AND RESTATED STOCK OPTION PLAN (Filed With SEC on September 10, 2014)
